Oncolytics Biotech (ONCY) REOLYSIN w/ REO 020 Met Primary Endpoint in Phase 2
Go back to Oncolytics Biotech (ONCY) REOLYSIN w/ REO 020 Met Primary Endpoint in Phase 2| Oncolytics Biotech, Inc. (NASDAQ: ONCY) | Delayed: 0.84 +0.04 (5.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.80 | 52 Week High | $1.37 | |||
| Open | $0.80 | 52 Week Low | $0.24 | |||
| Day High | $0.85 | P/E | N/A | |||
| Day Low | $0.80 | EPS | $0.00 | |||
| Volume | 544,156 | |||||
